Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-07

Clinical Trial Update: The Association Between IL17, Acute Respiratory Distress Syndrome and Acute Respiratory Failure

View source ↗

Summary

A Bayer-sponsored clinical trial investigating the association between IL-17 and acute respiratory distress syndrome (ARDS) and acute respiratory failure (ARF) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bayer | Conditions: Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Failure (ARF) | Status: COMPLETED